Insider Trading March 24, 2026

Reliance Global CFO Disposes $26,213 in Shares as Company Navigates Strategic Shifts

Joel Markovits sold 127,562 shares on March 24, 2026, amid a low-priced market valuation and corporate restructuring actions

By Ajmal Hussain EZRA
Reliance Global CFO Disposes $26,213 in Shares as Company Navigates Strategic Shifts
EZRA

Reliance Global Group Chief Financial Officer Joel Markovits sold 127,562 shares of common stock on March 24, 2026, at $0.2055 per share, a transaction totaling $26,213. The sale occurred while the stock trades near its 52-week low and the company reports ongoing strategic and financial adjustments, including an increased stake in Enquantum Ltd. and settlement agreements tied to a prior stock purchase.

Key Points

  • CFO Joel Markovits sold 127,562 shares on March 24, 2026, at $0.2055 per share, totaling $26,213.
  • Reliance Global's stock is trading near its 52-week low of $0.15, with a market capitalization of $4.29 million; the company reported negative EPS of $1.28 over the last twelve months.
  • Corporate actions include a 4% increase in ownership of Enquantum Ltd. to approximately 12%, securing an additional board seat, and settlement agreements that resolved prior claims with a final cash payment of $90,560.

Reliance Global Group, Inc. (NASDAQ: EZRA) reported an insider sale by Chief Financial Officer Joel Markovits on March 24, 2026, according to a Form 4 filing with the Securities and Exchange Commission. Markovits sold 127,562 shares of common stock at $0.2055 per share, producing a transaction value of $26,213.

Following the disposition, the filing indicates that Markovits directly holds 127.59 shares of Reliance Global Group, Inc. The sale comes while the share price is trading close to its 52-week low of $0.15, a steep decline from the 52-week high of $3.55. The company’s market capitalization is reported at $4.29 million.


Third-party valuation and financial condition

An InvestingPro analysis cited in the filing characterizes EZRA as appearing overvalued at current levels, noting that the company is rapidly drawing down cash and recorded a negative earnings per share of $1.28 over the last twelve months. The report is referenced as including further ProTips and extended metrics available via a Pro Research Report covering EZRA and more than 1,400 other U.S. equities.


Corporate developments and strategic moves

In related corporate disclosures, Reliance Global announced its fourth-quarter 2025 results, framing the period as one of strategic realignment with an increased emphasis on technology investments. The company said it saw improvements in balance sheet metrics and reiterated a focus on technology-driven growth initiatives.

Reliance Global also increased its stake in Enquantum Ltd. by 4 percentage points, taking total ownership to approximately 12% upon completion of a milestone under a structured agreement. That investment secured an additional board seat for Reliance Global under the terms of the agreement. Enquantum is identified in the disclosures as a business focused on quantum-resilient encryption technology.

In addition, the company disclosed entering into two settlement agreements and amending a key stock purchase agreement. Those settlements resolved claims tied to a prior stock purchase transaction, with Reliance Global agreeing to make a final cash payment of $90,560. The agreements include mutual releases of related obligations and terminate prior commitments connected to the transaction.


The filings and corporate updates present a picture of a company executing several financial and strategic maneuvers while operating with a low market valuation and an adverse recent earnings profile.

Risks

  • Liquidity and valuation risk: The company is trading near its 52-week low with a small market capitalization, indicating elevated market and liquidity risk for equity holders - impacts small-cap equity investors and market liquidity.
  • Financial performance risk: A reported negative EPS of $1.28 and ongoing cash burn noted in third-party analysis point to continued operating and capital risk - impacts creditors, equity holders, and overall corporate solvency considerations.
  • Deal and legal risk: Recent settlements and an amended stock purchase agreement required a $90,560 cash payment and the termination of prior commitments, highlighting transactional and counterparty risks tied to prior agreements - impacts corporate governance and investor confidence in the company’s contractual exposures.

More from Insider Trading

Foxx Development EVP Sells $14,941 in Shares; Board Adds New Director Mar 24, 2026 RenovoRx CEO Records Insider Buy of 24,300 Shares, Acquisition Valued at $0 Mar 24, 2026 RenovoRx CFO Purchases Shares and Warrants as Company Pursues Private Placement Mar 24, 2026 Ramaco Resources Director Disposes $8.2M in Class A Shares Over Three Days Mar 24, 2026 RenovoRx Director Acquires Shares and Warrants in $10,000 Private Placement Mar 24, 2026